Reporting of ethical requirements in phase III surgical trials.
J Med Ethics
; 40(10): 687-90, 2014 Oct.
Article
en En
| MEDLINE
| ID: mdl-23959837
BACKGROUND: Disclosure of obtaining informed consent from patients (ICP) and research ethics committee (REC) approval in published reports is sometimes omitted. To date, no disclosure data are available on surgical research. OBJECTIVE: Our aim was to assess whether REC approval and ICP were documented in surgical trials. STUDY DESIGN: Overall, 657 randomised trials, published between 2005 and 2010 in 10 international journals, were included. We collected the report rate of REC approval and ICP and contacted the corresponding author when ethical information was lacking. RESULTS: Among the 657 randomised controlled trials (RCT), 576 (87.7%) stated that an REC had approved the research, and 606 (92.2%) stated that ICP had been requested. Furthermore, 28 RCTs (4.3%) reported neither REC nor ICP. CONCLUSIONS: The phase III randomised surgical trials that were analysed were shown to have respected fundamental ethical principles in approximately 90% of the cases examines.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Cirugía General
/
Ensayos Clínicos Controlados Aleatorios como Asunto
/
Ensayos Clínicos Fase III como Asunto
Tipo de estudio:
Clinical_trials
Aspecto:
Ethics
Límite:
Humans
Idioma:
En
Revista:
J Med Ethics
Año:
2014
Tipo del documento:
Article
País de afiliación:
Francia